Cogent Biosciences, Inc. (COGT) stock
COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$27.85+0.41 (+1.49%)
Close on Nov 17, 2026Market cap $4.83BP/E –Yield –
Cogent Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Cogent Biosciences's price to book ratio was 9.5× on Nov 11, 2026, against 18.6× a year earlier. Over the last 5 years it ranged from 1.1× to 18.6×, with a median of 3.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 9.5× | −6.9 |
| 2025 | Dec 31, 2025 | 16.4× | +13.7 |
| 2024 | Dec 31, 2024 | 2.7× | +1.1 |
| 2023 | Dec 29, 2023 | 1.7× | −1.1 |
| 2022 | Dec 30, 2022 | 2.8× | +1.1 |
| 2021 | Dec 31, 2021 | 1.7× | −3.3 |
| 2020 | Oct 30, 2020 | 5.0× | +4.2 |
| 2019 | Dec 31, 2019 | 0.8× | −1.2 |
| 2018 | Dec 31, 2018 | 1.9× | – |
See a number that looks wrong?